Doctors say Vytorin-cancer link can't be ruled out MUNICH, Germany - Results from three studies of the cholesterol-lowering drug Vytorin are not enough to prove or rule out a possible link to a higher risk of cancer, so the drug should be used with great caution until more is known, editors of a leading medical journal urged Tuesday. The New England Journal of Medicine published results of the studies, which also were presented at a cardiology conference in Munich. Vytorin is a combination of Merck's Zocor, a long-sold statin drug, and Schering-Plough's Zetia, a newer type of medicine that lowers...
Read More...
[Source: Latest Articles - Posted by FreeAutoBlogger]
Doctors say Vytorin-cancer link can't be ruled out
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment